Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.3 HKD | +1.10% | +7.67% | -13.75% |
04-26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.75% | 3.55B | |
+2.64% | 108B | |
+9.28% | 105B | |
-1.08% | 23.46B | |
-13.94% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.01% | 17.19B | |
+6.43% | 13.99B | |
+35.11% | 12.53B |
- Stock Market
- Equities
- 9995 Stock
- News RemeGen Co., Ltd.
- UBS Upgrades RemeGen to Buy From Neutral, Adjusts Price Target to HK$75.03 From HK$108